- Home
- ADVM vs TCBS Comparison
ADVM vs TCBS Comparison
Compare ADVM & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- TCBS
- Stock Information
- Founded
- ADVM 2006
- TCBS 1934
- Country
- ADVM United States
- TCBS United States
- Employees
- ADVM N/A
- TCBS N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- TCBS Banks
- Sector
- ADVM Health Care
- TCBS Finance
- Exchange
- ADVM Nasdaq
- TCBS Nasdaq
- Market Cap
- ADVM 47.4M
- TCBS 48.8M
- IPO Year
- ADVM 2014
- TCBS N/A
- Fundamental
- Price
- ADVM $2.39
- TCBS $16.25
- Analyst Decision
- ADVM Strong Buy
- TCBS
- Analyst Count
- ADVM 5
- TCBS 0
- Target Price
- ADVM $23.80
- TCBS N/A
- AVG Volume (30 Days)
- ADVM 338.5K
- TCBS 3.4K
- Earning Date
- ADVM 08-11-2025
- TCBS 08-12-2025
- Dividend Yield
- ADVM N/A
- TCBS 0.94%
- EPS Growth
- ADVM N/A
- TCBS N/A
- EPS
- ADVM N/A
- TCBS 0.68
- Revenue
- ADVM $1,000,000.00
- TCBS $14,488,000.00
- Revenue This Year
- ADVM N/A
- TCBS N/A
- Revenue Next Year
- ADVM $18.82
- TCBS N/A
- P/E Ratio
- ADVM N/A
- TCBS $23.82
- Revenue Growth
- ADVM N/A
- TCBS 54.08
- 52 Week Low
- ADVM $1.78
- TCBS $13.52
- 52 Week High
- ADVM $10.14
- TCBS $17.92
- Technical
- Relative Strength Index (RSI)
- ADVM 44.75
- TCBS 58.71
- Support Level
- ADVM $2.11
- TCBS $15.90
- Resistance Level
- ADVM $2.60
- TCBS $16.15
- Average True Range (ATR)
- ADVM 0.22
- TCBS 0.09
- MACD
- ADVM -0.00
- TCBS -0.00
- Stochastic Oscillator
- ADVM 36.39
- TCBS 87.14
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.